FGEN
Price
$12.10
Change
+$0.79 (+6.98%)
Updated
Sep 5 closing price
Capitalization
48.93M
IMNM
Price
$10.52
Change
+$0.72 (+7.35%)
Updated
Sep 5 closing price
Capitalization
915.71M
72 days until earnings call
Interact to see
Advertisement

FGEN vs IMNM

Header iconFGEN vs IMNM Comparison
Open Charts FGEN vs IMNMBanner chart's image
FibroGen
Price$12.10
Change+$0.79 (+6.98%)
Volume$40.78K
Capitalization48.93M
Immunome
Price$10.52
Change+$0.72 (+7.35%)
Volume$1.36M
Capitalization915.71M
FGEN vs IMNM Comparison Chart in %
Loading...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGEN vs. IMNM commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGEN is a StrongBuy and IMNM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (FGEN: $12.10 vs. IMNM: $10.52)
Brand notoriety: FGEN and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGEN: 73% vs. IMNM: 170%
Market capitalization -- FGEN: $48.93M vs. IMNM: $915.71M
FGEN [@Biotechnology] is valued at $48.93M. IMNM’s [@Biotechnology] market capitalization is $915.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGEN’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • FGEN’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, FGEN is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGEN’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 7 bullish TA indicator(s).

  • FGEN’s TA Score: 5 bullish, 4 bearish.
  • IMNM’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than FGEN.

Price Growth

FGEN (@Biotechnology) experienced а +2.28% price change this week, while IMNM (@Biotechnology) price change was +10.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($916M) has a higher market cap than FGEN($48.9M). IMNM YTD gains are higher at: -0.942 vs. FGEN (-8.593). FGEN has higher annual earnings (EBITDA): -77.3M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. FGEN (23.4M). IMNM has less debt than FGEN: IMNM (4.14M) vs FGEN (73.7M). IMNM has higher revenues than FGEN: IMNM (12.6M) vs FGEN (7.35M).
FGENIMNMFGEN / IMNM
Capitalization48.9M916M5%
EBITDA-77.3M-187.92M41%
Gain YTD-8.593-0.942913%
P/E RatioN/AN/A-
Revenue7.35M12.6M58%
Total Cash23.4M268M9%
Total Debt73.7M4.14M1,779%
FUNDAMENTALS RATINGS
FGEN: Fundamental Ratings
FGEN
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGENIMNM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNIX23.42N/A
N/A
MFS Equity Income I
JNGIX78.25N/A
N/A
Janus Henderson Growth And Income D
PJEZX15.65N/A
N/A
PGIM US Real Estate Z
BMECX15.26-0.02
-0.13%
BlackRock High Equity Income Investor C
RYAWX113.71-0.42
-0.37%
Rydex S&P 500 Pure Growth H

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+6.98%
AVTX - FGEN
57%
Loosely correlated
+14.17%
JAGX - FGEN
32%
Poorly correlated
+7.27%
IMNM - FGEN
32%
Poorly correlated
+7.35%
COGT - FGEN
31%
Poorly correlated
+0.85%
DNTH - FGEN
31%
Poorly correlated
+7.46%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+7.35%
IDYA - IMNM
59%
Loosely correlated
+5.15%
DNTH - IMNM
55%
Loosely correlated
+7.46%
SYRE - IMNM
54%
Loosely correlated
+0.06%
RXRX - IMNM
53%
Loosely correlated
+1.99%
IPSC - IMNM
53%
Loosely correlated
+5.41%
More